Literature DB >> 11934012

Modulatory effect of phenolic fractions of Terminalia arjuna on the mutagenicity in Ames assay.

Kamaljit Kaur1, Saroj Arora, Subodh Kumar, Avinash Nagpal.   

Abstract

We determined the antimutagenicity of phenolic fractions of Terminalia arjuna (soluble and insoluble in chloroform) against two direct-acting mutagens, 4-nitro-o-phenylenediamine (NPD) and sodium azide, and against the S9-dependent mutagen 2-aminofluorene (2AF), in TA98 and TA100 tester strains of Salmonella typhimurium. We found that the phenolic fractions of T. arjuna inhibited revertants induced by the S9-dependent mutagen more remarkably than the direct-acting mutagens. Furthermore, the phenolic fractions showed maximum inhibition of 98% and 101.55%, respectively, in the pre-incubation mode of treatment against the mutations induced by 2AF. Overall, the fractions inhibited the revertants induced by S9-dependent mutagens more effectively than those induced by direct-acting mutagens. The percentage of inhibition was higher in the pre-incubation than with direct acting mutagens. The fraction insoluble in chloroform showed more inhibition than the soluble one, which corresponds to a higher polyphenol content in the insoluble fraction than in the soluble extract.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934012

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  2 in total

1.  Effect of mesenchymal stem cells on cytochrome-c release and inflammation in colon cancer induced by 1,2-dimethylhydrazine in Wistar albino rats.

Authors:  Afrah F Alkhuriji; Seham G Alsaiari; Suliman Y Alomar; Alaa A Alnafjan; Hussah Alobaid; Manal F El-Khadragy
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

2.  Ellagic acid derivatives from Terminalia chebula Retz. downregulate the expression of quorum sensing genes to attenuate Pseudomonas aeruginosa PAO1 virulence.

Authors:  Sajal Sarabhai; Prince Sharma; Neena Capalash
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.